{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-104204","form_type":"8-K","ticker":"PRLD","cik":"0001678660","company_name":"Prelude Therapeutics Inc","filed_at":"2026-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.867736+00:00","generated_at":"2026-05-15T13:38:11.812657+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Prelude Therapeutics files $25M ATM equity offering via Jefferies","bullets":["Filed prospectus supplement to sell up to $25M common stock under existing Sales Agreement with Jefferies LLC.","Offering supplements prior $75M capacity; shares sold from time to time at market prices.","Legal opinion from Morgan, Lewis & Bockius LLP filed as Exhibit 5.1.","Proceeds intended for general corporate purposes; no specific use disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-104204","json":"https://secwatch.observer/filing/0001193125-26-104204.json","markdown":"https://secwatch.observer/filing/0001193125-26-104204.md","text":"https://secwatch.observer/filing/0001193125-26-104204.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1678660/000119312526104204/0001193125-26-104204-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1678660/000119312526104204/d916869d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T13:38:11.812657+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}